Leap Therapeutics, Inc. (NASDAQ: LPTX) reported Q2 EPS of ($0.15), $0.05 worse than the analyst estimate of ($0.10).

For earnings history and earnings-related data on Leap Therapeutics, Inc. (LPTX) click here.